Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

[1]  S. Jhanwar,et al.  Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. , 1999, Cancer research.

[2]  Takashi Takahashi,et al.  Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers , 1998, Oncogene.

[3]  B. Van Houten,et al.  Asbestos increases mammalian AP-endonuclease gene expression, protein levels, and enzyme activity in mesothelial cells. , 1998, Cancer research.

[4]  A. Winterpacht,et al.  Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. , 1997, Cancer research.

[5]  S. Jhanwar,et al.  Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. , 1997, Cancer research.

[6]  H. Vainio,et al.  Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. , 1997, Scandinavian journal of work, environment & health.

[7]  D. Yates,et al.  Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. , 1997, Thorax.

[8]  P. Bugert,et al.  Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas , 1997, Genes, chromosomes & cancer.

[9]  M. Morgan,et al.  Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. , 1997, Cancer research.

[10]  S. Jhanwar,et al.  Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. , 1996, Cancer research.

[11]  K. Pelin,et al.  Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. , 1996, Cancer genetics and cytogenetics.

[12]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[13]  S. Jhanwar,et al.  High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Wellenreuther,et al.  Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. , 1995, Cancer research.

[15]  T. Polascik,et al.  Novel suppressor loci on chromosome 14q in primary bladder cancer. , 1995, Cancer research.

[16]  J. Minna,et al.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. , 1995, Cancer research.

[17]  O. Olopade,et al.  p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. , 1994, Cancer research.

[18]  W. M. Linehan,et al.  Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors , 1994, Genes, chromosomes & cancer.

[19]  J Piper,et al.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.

[20]  J. Cheng,et al.  Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma , 1994, Genes, chromosomes & cancer.

[21]  S. Jhanwar,et al.  Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. , 1993, Cancer research.

[22]  D. Ward,et al.  Human apurinic endonuclease gene (APE): structure and genomic mapping (chromosome 14q11.2-12). , 1992, Human molecular genetics.

[23]  B. Demple,et al.  Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Goodglick,et al.  Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. , 1990, Cancer research.

[25]  T. H. van der Kwast,et al.  Cytogenetic analysis of malignant mesothelioma. , 1990, Cancer genetics and cytogenetics.

[26]  S. Knuutila,et al.  Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. , 1989, British Journal of Cancer.

[27]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[28]  B. Mossman,et al.  Generation of superoxide (O2-.) from alveolar macrophages exposed to asbestiform and nonfibrous particles. , 1987, Cancer research.

[29]  K. Browne,et al.  MESOTHELIOMA REGISTRY DATA , 1986, The Lancet.

[30]  J. Wagner,et al.  Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province , 1960, British journal of industrial medicine.

[31]  S. Knuutila,et al.  Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. , 1998, British Journal of Cancer.

[32]  S. Knuutila,et al.  Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. , 1997, British Journal of Cancer.